Results 161 to 170 of about 2,595,852 (298)

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Preserving scientific integrity in academic publishing: Navigating artificial intelligence, journal policies, and the impact factor as a quality indicator. [PDF]

J Exp Orthop
Kayaalp ME, Zaffagnini S, Mont MA, Karlsson J, Reider B, Ayeni O, Heyse T, Madry H, Herbst E, Milano G, Musahl V, Becker R, Hirschmann MT.   +12 more
europepmc   +1 more source

Etiological factors of severe acute malnutrition and impact of nutrition rehabilitation centre: a prospective observational study from Bhavnagar

, 2021
Vibhuti D. Gamit, Jayendra R. Gohil, Adithya Nikhileshwar B., Tanmay P Vagh   +3 more
openalex   +2 more sources

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

JSM Impact Factor

The Journal of Sexual Medicine, 2008
openaire   +2 more sources

Impact Factor Insights 2025: Analysis of Pakistani Academic Journals. [PDF]

Pak J Med Sci
Meo SA, Jawaid SA.
europepmc   +1 more source

An Impact Factor for Neuro-Oncology Practice. [PDF]

Neurooncol Pract, 2023
Taphoorn MJB.
europepmc   +1 more source

Access to and use of medicines in the Annapurna region of Western Nepal and possible impacting factors [PDF]

, 2019
Bhuvan KC, Susan Heydon, Pauline Norris
openalex   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Recent Trends and Expectations of Progress in Rehabilitation Medicine: Celebrating the First Impact Factor. [PDF]

Prog Rehabil Med
Momosaki R.
europepmc   +1 more source